Equities

Electromed Inc

Electromed Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)13.94
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change+33.91%
  • Beta0.4639
Data delayed at least 15 minutes, as of Apr 18 2024 21:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. The Company applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. Its SmartVest Connect wireless technology is a personalized HFCWO therapy management portal for patients with compromised pulmonary function. The SmartVest Connect app securely connects to the SmartVest System through Bluetooth technology. The Company also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.

  • Revenue in USD (TTM)51.69m
  • Net income in USD3.94m
  • Incorporated1992
  • Employees170.00
  • Location
    Electromed Inc500 6th Ave NWNEW PRAGUE 56071United StatesUSA
  • Phone+1 (952) 758-9299
  • Websitehttps://smartvest.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Myomo Inc19.24m-8.15m80.33m101.00--8.51--4.18-0.2726-0.27260.62650.33131.563.788.99190,506.40-65.86-81.78-104.03-115.2768.5168.50-42.34-85.762.16--0.00--23.7051.0924.00--2.82--
Vuzix Corp13.96m-41.03m81.55m111.00--0.834--5.84-0.6475-0.64750.22031.510.11651.062.56125,769.90-34.23-42.85-36.25-46.2010.631.97-293.88-287.159.39--0.00---10.1016.41-0.957--47.65--
KORU Medical Systems Inc28.52m-13.74m94.16m82.00--4.62--3.30-0.3012-0.30120.62540.44570.80572.397.50347,776.50-38.82-17.60-46.28-20.2958.5959.44-48.18-21.703.77--0.0351--2.2310.44-58.65--11.10--
Vivani Medical Inc0.00-25.65m99.24m44.00--4.44-----0.5042-0.50420.000.40680.00----0.00-52.93-56.58-60.80-67.66-------2,868.72----0.00-------84.69--40.33--
Envoy Medical Inc316.00k-29.91m100.16m34.00------316.95-2.60-2.600.0207-0.0899------9,294.12---------149.68---9,464.56--0.8169-266.25----33.33---87.83------
Xtant Medical Holdings Inc91.30m660.00k109.02m207.00--2.1228.431.19-0.0042-0.00420.7550.39451.191.325.78441,072.500.8636-10.381.15-14.6860.7561.080.7229-8.661.22-4.020.2997--57.504.81107.78--18.47--
Fonar Corp102.42m12.16m112.90m561.009.650.6895.431.101.741.7414.6024.420.512420.351.44182,570.608.338.738.649.6045.6748.3316.2516.399.15--0.0055--1.083.89-24.71-15.058.48--
Neuronetics Inc71.35m-30.19m114.80m203.00--3.26--1.61-1.06-1.062.491.180.61322.094.86351,468.00-25.95-28.02-33.60-34.7375.1375.73-42.31-51.044.33-5.280.6342--9.426.2218.76--18.57--
Outset Medical Inc130.38m-172.80m116.33m480.00--0.9213--0.8923-3.49-3.492.642.440.36522.014.27271,616.70-48.41-41.40-56.97-47.2922.245.71-132.54-159.054.37-67.800.5143--13.00130.43-6.04--14.27--
Delcath Systems Inc2.07m-47.68m119.44m76.00--6.77--57.84-2.98-2.980.12730.69310.07310.23876.8027,171.05-168.85-116.57-377.02-243.2169.2571.02-2,308.86-1,235.372.06-26.530.3915---24.05-9.53-30.60---5.26--
Electromed Inc51.69m3.94m119.96m170.0031.002.9725.782.320.44980.44985.914.691.172.952.27304,076.508.917.8610.399.1476.5176.257.627.385.25--0.000.0015.3811.1737.3511.0024.58--
TELA Bio Inc58.45m-46.66m126.95m227.00--6.68--2.17-2.06-2.062.560.77080.80131.477.15257,502.20-63.97-52.00-80.09-60.9568.6265.32-79.83-107.653.45-8.440.6821--41.1347.85-5.35---17.12--
Akso Health Group - ADR2.20m-17.07m145.19m12.00------65.91-0.7466-0.24610.0963--0.11661.910.3202183,560.00-89.84-17.36-224.28-23.997.56---770.59-256.641.36-24.020.6531--119.69-34.25-221.68------
Clearpoint Neuro Inc23.96m-22.09m145.91m107.00--6.28--6.09-0.8979-0.89790.97360.85890.48811.208.15223,878.50-45.01-34.75-52.63-39.6756.8364.75-92.21-76.913.80--0.3197--16.5626.64-34.40--75.30--
Inogen Inc315.66m-102.45m165.39m834.00--0.8074--0.5239-4.42-4.4213.628.780.86346.766.01378,489.20-28.02-8.23-34.53-9.5340.1444.54-32.46-10.312.56--0.00---16.32-2.49-22.30--26.34--
InfuSystem Holdings Inc125.79m872.00k165.65m499.00196.573.1612.341.320.03960.03965.862.471.2411.176.85252,074.100.86214.601.015.6950.1756.430.69334.071.541.880.35750.0014.4413.384,744.44--6.01--
Data as of Apr 18 2024. Currency figures normalised to Electromed Inc's reporting currency: US Dollar USD

Institutional shareholders

27.71%Per cent of shares held by top holders
HolderShares% Held
Summers Value Partners LLCas of 14 Dec 2023550.49k6.40%
Punch & Associates Investment Management, Inc.as of 31 Dec 2023417.29k4.85%
The Vanguard Group, Inc.as of 31 Dec 2023359.42k4.18%
Dimensional Fund Advisors LPas of 31 Dec 2023287.30k3.34%
Acadian Asset Management LLCas of 31 Dec 2023220.50k2.56%
RBC Capital Markets LLC (Investment Management)as of 31 Dec 2023140.22k1.63%
Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 30 Jun 2023136.19k1.58%
Bridgeway Capital Management LLCas of 31 Dec 2023108.74k1.26%
GAMCO Asset Management, Inc.as of 31 Dec 202384.00k0.98%
Hunter Associates Investment Management LLCas of 31 Dec 202380.50k0.94%
More ▼
Data from 14 Dec 2023 - 31 Jan 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.